Skip to main navigation Skip to search Skip to main content

Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.

  • Haikun Song
  • , H Li
  • , Shimeng Guo
  • , Yuyin Pan
  • , Yuhua Fu
  • , Zijian Zhou
  • , Z Li
  • , Xue Wen
  • , Xiaoli Sun
  • , Bingqing He
  • , Haifeng Gu
  • , Quan Zhao
  • , Cen Wang
  • , Ping An
  • , Shouqing Luo
  • , Youhong Hu
  • , Xin Xie
  • , Boxun Lu*
    • *Corresponding author for this work
  • Fudan University
  • CAS - Shanghai Institute of Materia Medica
  • ShanghaiTech University

Research output: Contribution to journal › Article › peer-review

28 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science